+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-19Number of Pages: 138

Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023

Endocrine testing has been witnessing a widespread application since the last few years. Analysts expect the trend to rise steadily in the near future due to growing prevalence of obesity and diabetes across the world. In 2014, the global opportunity in endocrine testing was worth US$6.1 bn. Rising at a CAGR of 8.50% between 2015 and 2023, it is likely to increase to US$12.8 bn by 2023.

The rise in the incidence of diabetes, propelled by the increasing geriatric as well as obese population, has fueled the application of endocrine testing in determining the insulin level in a human body. The prevalence of obesity, in general, has also boosted the demand for this technology significantly, as it leads to a number of life-threatening diseases such as cardiac disorders, stroke, hypertension, and several types of cancer.

Going forward, the unmet medical needs in emerging countries are likely to provide ample opportunities for this market to grow. Leading players are aggressively focusing on expanding their reach in these economies through mergers, acquisitions, and strategic partnerships with local players.

Commercial Laboratories to Remain Leading End User of Endocrine Testing

Physician offices, home-based tests, hospitals, ambulatory care centers, and commercial laboratories are the prime end users of endocrine testing technology. Among these, commercial laboratories acquired the leading position in 2014 and is projected to remain on the top throughout the forecast period. The presence of skilled professionals, increased usage of specialized diagnostics tools, and advanced diagnostics facilities are the prominent factors that have fueled the application of endocrine testing techniques in these laboratories over the recent past.

In near future, the advent of tele-health services is expected to increase the application of endocrine testing in commercial laboratories considerably. The adoption of this technology will also witness a significant rise in the home-based tests segment in the coming years, owing to the instant results provided by endocrine test kits.

Endocrine Testing to Report Fastest Growth Rate in Asia Pacific

The global endocrine testing market stretches across North America, Asia Pacific, Europe, and the Rest of the World. North America emerged as the key contributor to the revenue generated in this market in 2014 with a share of more than 40%. The growing preference for a healthy lifestyle among people has increased the adoption of this technology in this region.

Additionally, the continual advancements in technology are expected to escalate the application of endocrine testing in North America over the next few years. Asia Pacific, however, is likely to provide the market players with most promising opportunities in the near future, owing to the presence of untapped emerging countries. The demand for endocrine testing in Asia Pacific is anticipated to rise at the fastest CAGR of 10.30% during the period from 2015 to 2023.

F-Hoffmann La Roche Ltd. and Abbott Laboratories lead the global market for endocrine testing. Other key players operating in this market are DiaSorin S.p.A., Bio-Rad Laboratories Inc., bioMerieux SA, Biomedical Diagnostics, Agilent Technologies, AB Sciex Pte. Ltd., LabCorp, Siemens AG, and Thermo Fisher Scientific Inc.


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Endocrine Testing Market Revenue, by Diagnostic Technologies, 2014 & 2023 (Value %)
2.2 Global Endocrine Testing Market Revenue, by End-User, 2014 & 2023 (US$ Million)
2.3 Global Endocrine Testing Market Revenue, by Tests, 2014 (US$ Million)
2.4 Global Endocrine Testing Market Revenue, by Geography, 2014 & 2023 (US$ Million)
2.5 Global Endocrine Testing Market, 2014 & 2023: Market Snapshot 

Chapter 3 Industry Analysis
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Drivers
              3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
              3.2.1.2 Consistent rise in geriatric population Worldwide
              3.2.1.3 Technological advancements
      3.2.2 Restraints
              3.2.2.1 High cost of technology
              3.2.2.2 Lack of healthcare awareness in emerging economies
      3.2.3 Opportunity
              3.2.3.1 Investment Opportunity
      3.2.4 Endocrine Testing Market: Porter’s Five Forces Analysis
      3.2.5 Market Attractiveness Analysis – Endocrine Testing Market, by Geography, 2014
      3.2.6 Competitive Landscape 
              3.2.6.1 Global Endocrine Testing Market: Market Share, by Key Players, 2014   (%)
              3.2.6.2 At Home and Physician Office Endocrine Tests Market Revenue, by Tests, 2014 (US$ Million)

Chapter 4 Market Segmentation – By Tests
4.1 Introduction
4.2 Global Estradiol (E2) Test Market Revenue, 2013-2023 (US$ Mn)
4.3 Global Follicle Stimulating Hormone (FSH) Test Market Revenue, 2013-2023 (US$ Mn)
4.4 Global Human Chorionic Gonadotropin (hCG) Test  Market Revenue, 2013-2023 (US$ Mn)
4.5 Global Luteinizing Hormone (LH) Test Market Revenue, 2013-2023 (US$ Mn)
4.6 Global Dehydroepiandrosterone sulfate (DHEAS) Test Market Revenue, 2013-2023 (US$ Mn)
4.7 Global Progesterone Test Market Revenue, 2013-2023 (US$ Mn)
4.8 Global Testosterone Test Market Revenue, 2013-2023 (US$ Mn)
4.9 Global Thyroid Stimulating Hormone (TSH) Test Market Revenue, 2013-2023 (US$ Mn)
4.10 Global Prolactin Test Market Revenue, 2013-2023 (US$ Mn)
4.11 Global Cortisol Test Market Revenue, 2013-2023 (US$ Mn)
4.12 Global Insulin Test Market Revenue, 2013-2023 (US$ Mn)
4.13 Global Other Endocrine Tests Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 Market Segmentation – By Diagnostic Technology
5.1 Global Tandem Mass Spectrometry Market Revenue, 2013-2023 (US$ Mn)
5.2 Global Immunoassay Technologies Market Revenue, 2013-2023 (US$ Mn)
5.3 Global Monoclonal and Polyclonal Antibody Technologies Market Revenue, 2013-2023 (US$ Mn)
5.4 Global Sensor Technologies Market Revenue, 2013-2023 (US$ Mn)
5.5 Global Clinical Chemistry Technologies Market Revenue, 2013-2023 (US$ Mn)
5.6 Global Others Technologies Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 Market Segmentation – By End User
6.1 Global Hospitals Market Revenue, 2013-2023 (US$ Mn)
6.2 Global Commercial Laboratories Market Revenue, 2013-2023 (US$ Mn)
6.3 Global Ambulatory Care Centers Market Revenue, 2013-2023 (US$ Mn)
6.4 Global Home Based tests Market Revenue, 2013-2023 (US$ Mn)
6.5 Global Physician Offices Market Revenue, 2013-2023 (US$ Mn)

Chapter 7 Market Segmentation – By Geography
7.1 North America Market Revenue, 2013-2023 (US$ Mn)
7.2 Europe Market Revenue, 2013-2023 (US$ Mn)
7.3 Asia Pacific Market Revenue, 2013-2023 (US$ Mn)
7.4 Rest of the World Market Revenue, 2013-2023 (US$ Mn)

Chapter 8 Recommendations

Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AB Sciex Pte. Ltd.
9.3 Agilent Technologies
9.4 Biomedical Diagnostics 
9.5 bioMerieux SA 
9.6 Bio-Rad Laboratories, Inc.
9.7 DiaSorin S.p.A.
9.8 F. Hoffmann-La Roche Ltd.
9.9 Laboratory Corporation of America Holdings (LabCorp)
9.10 Ortho-Clinical Diagnostics 
9.11 Quest Diagnostics
9.12 Siemens Healthcare GmbH (Siemens AG)
9.13 Sysmex Corporation
9.14 Thermo Fisher Scientific, Inc.

The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostic technologies, end-users, and geography. This report studies the current scenario as well as future market potential for endocrine testing globally. This report comprises an elaborate executive summary, which includes a market snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global endocrine testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the endocrine testing market.

Based on test, the global endocrine testing market has been segmented into estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global endocrine testing market has been categorized into North America, Europe, Asia Pacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.

The global endocrine testing market is segmented as follows:

Global Endocrine Testing Market, by Test, 2013-2023 (USD Million)

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others (Gastrin, Thymosin, Secretin, etc.)

Global Endocrine Testing Market, by Diagnostic Technology, 2013 – 2023 (USD Million)

  • Tandem Mass spectrometry
  • Immunoassay (Enzyme immunoassays, Radioimmunoassays  (RIA)) Technologies
  • Monoclonal and Polyclonal Antibody Technologies
  • Sensor (Electrochemical, Biosensors, etc.) Technologies
  • Clinical Chemistry Technologies
  • Others (Liquid Chromatography + Mass Spectrometry (LC-MS)

Global Endocrine Testing Market, by End User, 2013 – 2023 (USD Million)

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Home Based Tests
  • Physician Offices

Global Endocrine Testing Market, by Geography, 2013 – 2023 (USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Rest of the World (RoW)